ECHA’s Committee for Socio-Economic Analysis issues final opinion in favor of banning endocrine disrupting phthalates DEHP, DBP, DIBP, and BBP in consumer articles; all 4 phthalates relevant for food contact materials
Next meeting on EDC criteria scheduled
EU Member States to discuss and possibly vote on Commission’s draft criteria to identify endocrine disruptors on July 4, 2017
Endocrine experts concerned about EU EDC criteria
Endocrinology societies send letter to EU Commission, urge Member States to work on EDC criteria that better protect the environment and human health
BPA recognized as human endocrine disruptor
ECHA Member State Committee identifies bisphenol A as a substance of very high concern because of its endocrine disrupting effects in humans, in addition to its reprotoxic properties
Vote on EDC criteria on hold
EU Commission presents latest revised draft of criteria to identify endocrine disruptors to Member States; no formal vote taken; next meeting not yet scheduled
In vitro testing of paper and board FCMs
Scientists test paper and board FCMs in 8 in vitro bioassays; all 20 samples showed positive responses in at least one of the assays; chemicals in paper and board FCMs require further investigation to ensure safety
New test methods for EDCs needed
JRC expert survey identifies gaps in test methods for evaluating endocrine disruptors; new methods for thyroid, metabolic, immune disorders, as well as hormone-related cancers seen as priority
EDC criteria vote postponed
EU Commission delays vote on draft criteria for identification of endocrine disrupting chemicals, scheduled to be held at the latest meeting of the Standing Committee on Plants, Animals, Food and Feed
Case study on different sets of EDC criteria
Industry-sponsored study assesses four natural substances using EU Commission’s different options for criteria to identify endocrine disruptors; highlights need for including potency considerations in EDC criteria
Vote on EDC criteria scheduled
Next meeting of EU Commission and Member States on revised criteria to identify endocrine disrupters to take place on May 17-18, 2017; vote foreseen despite persisting concerns